{"id":18311,"date":"2022-03-14T17:24:55","date_gmt":"2022-03-14T21:24:55","guid":{"rendered":"https:\/\/caloriecontrol.org\/?p=18311"},"modified":"2022-03-18T11:16:09","modified_gmt":"2022-03-18T15:16:09","slug":"network-analysis-reinforces-benefits-of-low-and-no-calorie-sweetened-beverages","status":"publish","type":"post","link":"https:\/\/caloriecontrol.org\/network-analysis-reinforces-benefits-of-low-and-no-calorie-sweetened-beverages\/","title":{"rendered":"Network Analysis Reinforces Benefits of Low- And No- Calorie Sweetened Beverages"},"content":{"rendered":"\n

(Download<\/a>)<\/p>\n\n\n\n

McGlynn ND, Khan TA, Wang L, et al.<\/p>\n\n\n\n

JAMA Network Open. <\/em>2022;5(3):e222092. doi:10.1001\/jamanetworkopen.2022.2092<\/p>\n\n\n\n

A recent review published in JAMA Network Open<\/em> examined the association of low- and no-calorie sweetened beverages (LNCSBs) with body weight and cardiometabolic risk factors in adults with and without diabetes. Recent trials and reviews have reported inconsistent findings regarding these outcomes, and methodological considerations limit the conclusions that can be drawn from their reported results. For example, the authors note that the syntheses of randomized controlled trials (RCTs) do not fully account for the calories available to be displaced by LNCSBs, leading to an underestimation of the outcome of LNCSBs. In an effort to update the recommendations of the European Association for the Study of Diabetes, the Diabetes and Nutrition Study Group commissioned this new systematic review and meta-analysis to summarize evidence regarding the association of LNCSBs with intermediate cardiometabolic outcomes, including:<\/p>\n\n\n\n